Psychemedics Corporation

PMD

US7443752057

Healthcare Facilities & Services

Market Closed - Nasdaq Other stock markets 02:00:00 24/05/2024 am IST			5-day change	1st Jan Change
2.69 ^USD	+4.26%		+4.67%	-9.12%

28/03	Psychemedics Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	CI
25/03	North American Morning Briefing : Tech in Focus on -2-	DJ

Psychemedics Corporation Announces Retirement of Walter S. Tomenson, Jr. from Board

June 10, 2022 at 02:30 am IST

Psychemedics Corporation announced that Walter S. Tomenson, Jr. will be retiring from the Board as of the completion of his current term ending at the 2022 Annual Meeting.

Latest news about Psychemedics Corporation

Psychemedics Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	28/03	CI
North American Morning Briefing : Tech in Focus on -2-	25/03	DJ
North American Morning Briefing : Investors -2-	18/03	DJ
Psychemedics Corporation Announces Relocation of its Corporate Headquarters to Dallas, Texas	02/01	CI
Psychemedics Relocates Headquarters to Dallas; Shares Rise	02/01	MT
Tranche Update on Psychemedics Corporation's Equity Buyback Plan announced on March 18, 2008.	14/11	CI
Earnings Flash (PMD) PSYCHEMEDICS CORPORATION Posts Q3 Revenue $5.7M	10/11	MT
Psychemedics Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	10/11	CI
Psychemedics Corporation Appoints Shannon Shoemaker as Chief Revenue Officer	22/23/22	CI
Psychemedics Names Chief Revenue Officer	22/23/22	MT
Psychemedics Corporation Announces Charles Doucot, to Leave as Executive Vice President, Effective September 15, 2023	01/23/01	CI
Tranche Update on Psychemedics Corporation's Equity Buyback Plan announced on March 18, 2008.	15/23/15	CI
Earnings Flash (PMD) PSYCHEMEDICS CORPORATION Posts Q2 Revenue $5.5M	12/23/12	MT
Psychemedics Corporation Determines to Eliminate the Dividend	12/23/12	CI
Psychemedics Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	12/23/12	CI
Psychemedics Corporation Announces Board Changes	14/23/14	CI
Psychemedics Corporation Announces CEO Changes	14/23/14	CI
Psychemedics Says Brian Hullinger to Succeed Ray Kubacki as CEO, Effective Aug. 17	13/23/13	MT
Tranche Update on Psychemedics Corporation's Equity Buyback Plan announced on March 18, 2008.	12/23/12	CI
Earnings Flash (PMD) PSYCHEMEDICS CORPORATION Posts Q1 Revenue $5.9M	10/23/10	MT
Psychemedics Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023	10/23/10	CI
Psychemedics Corporation Declares Cash Dividend, Payable on June 8, 2023	10/23/10	CI
Tranche Update on Psychemedics Corporation's Equity Buyback Plan announced on March 18, 2008.	27/23/27	CI
Earnings Flash (PMD) PSYCHEMEDICS CORPORATION Posts Q4 Revenue $5.7M	22/23/22	MT
Psychemedics Corporation Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022	22/23/22	CI

Chart Psychemedics Corporation

Duration

Period

More charts

Psychemedics Corporation is a hair drug testing company. The Company provides testing services for the detection of drugs of abuse through the analysis of hair samples. Its testing methods utilize a patented technology that digests the hair and releases drugs trapped in the hair without destroying the drugs. The Company customizes its enzyme immunoassay (EIA) procedures to drug test hair samples. It provides screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, phenylcyclohexyl piperidine (PCP), amphetamines (including ecstasy, eve, and Adderall), opiates (including heroin, hydrocodone, hydromorphone, oxycodone and codeine), synthetic cannabinoids (including K2, Spice, Blaze), benzodiazepines (Xanax, Valium, and Ativan), nicotine, Fentanyl, and alcohol. The Company markets its corporate drug testing services through its own sales force, distributors, and partners. It markets its home drug testing service, PDT-90, through the Internet.

Sector

Healthcare Facilities & Services

Calendar

06/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Medical & Diagnostic Laboratories

	1st Jan change	Capi.
PSYCHEMEDICS CORPORATION	-9.12%	14.98M
SONIC HEALTHCARE LIMITED	-20.70%	7.83B
DR. LAL PATHLABS LIMITED	+0.14%	2.58B
SYNLAB AG	-8.23%	2.48B
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.	-40.47%	2.46B
NEOGENOMICS, INC.	-14.15%	1.84B
FLEURY S.A.	-20.84%	1.53B
DIAN DIAGNOSTICS GROUP CO.,LTD.	-42.17%	1.22B
METROPOLIS HEALTHCARE LIMITED	+16.01%	1.2B
VIJAYA DIAGNOSTIC CENTRE LIMITED	+14.92%	961M